Prostate Cancer
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.
June 11, 2024
Surgical gestures to evaluate apical dissection of robot-assisted radical prostatectomy.
June 10, 2024
Receipt of prostate-specific antigen test in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.
June 7, 2024
Natural language processing pipeline to extract prostate cancer-related information from clinical notes.
June 7, 2024